The Penicillins and Streptomycins dosage market in Madagascar has shown fluctuations over the past decade. From an initial value of 16.469 million USD in 2013, it reached 29.263 million USD in 2023. The market has seen notable variations, with significant growth in 2014 and 2020, while a decline was observed in 2015 and 2022. Over the past five years, the compounded annual growth rate (CAGR) was 2.74%, indicating moderate growth. The market size in 2023 reflects a value increase compared to 2022, with a slight year-on-year growth of 2.49%.
Looking ahead, future trends to watch for include the impact of healthcare policy changes, advancements in generic drug manufacturing, and potential shifts in disease prevalence affecting antibiotic demand. Global supply chain dynamics and economic factors will also influence market development in Madagascar.
